The nervous system transmits signals between neurons via neurotransmitter release during synaptic vesicle fusion. In order to observe neurotransmitter uptake and release from individual presynaptic terminals directly, we designed fluorescent false neurotransmitters as substrates for the synaptic vesicle monoamine transporter. Using these probes to image dopamine release in the striatum, we made several observations pertinent to synaptic plasticity. We found that the fraction of synaptic vesicles releasing neurotransmitter per stimulus was dependent on the stimulus frequency. A kinetically distinct "reserve" synaptic vesicle population was not observed under these experimental conditions. A frequency-dependent heterogeneity of presynaptic terminals was revealed that was dependent in part on D2 dopamine receptors, indicating a mechanism for frequency-dependent coding of presynaptic selection.
Fluorescent False Neurotransmitters Visualize Dopamine Release from Individual Presynaptic Terminals D ecision making, memory, and learning require activation and modification of particular synapses. Synaptic transmission in turn requires neurotransmitter accumulation into synaptic vesicles followed by neurotransmitter release during synaptic vesicle fusion with the plasma membrane. Optical methods have been developed to observe synaptic vesicle membrane fusion (1) (2) (3) (4) , but there has been no means for observing neurotransmitter release from individual synapses in the brain.
We designed optical tracers of monoamine neurotransmitters, or fluorescent false neurotransmitters (FFNs), inspired by classic reports that tyramine, amphetamine, and other phenylethylamines can be taken up into secretory vesicles and discharged during exocytosis (5) . We designed FFNs by targeting neuronal vesicular monoamine transporter 2 (VMAT2), which carries monoamine neurotransmitters from the cytoplasm into synaptic vesicles (6) . VMAT2 is relatively nonspecific and transports cellular monoamines (such as dopamine, serotonin, and norepinephrine) as well as synthetic amines (such as amphetamine, 3,4-methylenedioxymethamphetamine, and 1-methyl-4-phenylpyridinium) (7, 8) . We predicted that bulkier fluorescent monoamines might also be substrates (9) and developed compound FFN511 [ Fig. 1A and fig. S1 ; design criteria are in the supporting online material (SOM)] (10). FFN511 inhibited serotonin binding to VMAT2-containing membranes, providing an apparent half maximal inhibitory concentration IC 50 of 1 mM, a value close to dopamine itself (7) .
In adrenal chromaffin cells, catecholamines are stored in large dense core vesicles (LDCVs) that possess the vesicular monoamine transporter 1 (VMAT1). FFN511 accumulated in a pattern consistent with LDCVs in cultured mouse chromaffin cells (Fig. 1B) , and the accumulation was abolished by the lipophilic base chloroquine, which collapses the vesicle pH gradient ( fig. S2 ) (11) . Exposure to 350 nM FFN511 (30 min) had no effect on the quantal size of evoked catecholamine release ( fig. S3) , and total internal reflection fluorescence microscopy (TIRFM) showed that FFN511 undergoes stimulation-dependent exocytosis from LDCVs (Fig. 1C, fig. S4 , and movie S1) (12) .
We then examined FFN511 accumulation and release in mouse brain using multiphoton microscopy. FFN511 incubation of acutely prepared slices from the striatum resulted in fluorescent puncta that correlated well with the size of axon terminals (~1 mm) (Fig. 2) . No label was observed in striatal cell bodies [chiefly medium spiny neurons (MSNs)], indicating that accumulation into lysosomes or other acidic organelles was below detection limits. As expected, no labeling was observed in the corpus callosum (CC), which lacks monoamine terminals, and sparser distribution was observed in the cortex (Fig. 2 , A and G) and hippocampus than in the striatum.
Extensive experimental evidence was accumulated in order to confirm that FFN511 labels dopamine presynaptic terminals in striatum, including (i) the overlap of FFN511 signal with that of green fluorescent protein (GFP) by using striatal slices prepared from transgenic mice expressing GFP under the control of the tyrosine hydroxylase (TH) promoter ( Fig. 2E and fig. S7 ). Furthermore, amphetamine (20 mM for 20 min), which redistributes vesicular dopamine to the cytosol and induces dopamine release without synaptic vesicle fusion (15) , caused a substantial loss of fluorescence in striatum (Fig. 2F ) and the medial prefrontal cortex (mPFC) (Fig. 2G) .
Levels of FFN511 sufficient to label terminals in the striatum (10 mM for 30 min) did not significantly alter evoked dopamine release as measured with cyclic voltammetry (a reduction of 7.5 T 4%, mean T SEM, n = 4 slices, P > 0.5). FFN511 cannot be oxidized during electrochemical detection, and higher concentrations of FFN511 (40 mM) decreased the evoked dopamine release by 35.4 T 1.4% (n = 3 slices), presumably by displacing vesicular dopamine. The probe thus acts as an optical tracer of dopamine, and is sufficiently fluorescent so as to provide resolution of individual dopamine terminals at concentrations that do not interfere with normal catecholamine accumulation and transmission. We examined activity-dependent release of FFN511 from dopamine synaptic terminals using a "pulse-chase" protocol in which an acute striatal brain slice was labeled with FFN511 (10 mM for 30 min) and then stimulated with current applied by a bipolar electrode ( Fig. 3A and movie S3) or high potassium ( fig. S8 ). Bipolar stimulation at 1, 4, and 20 Hz each evoked exponential destaining ( Fig. 3B ) with a mean half-time (t 1/2 ) of destaining of 330, 257, and 114 s, respectively, whereas negligible destaining occurred in the absence of stimulation or when stimuli were applied, but calcium channels were blocked by 200 mM cadmium (Fig.  3B ). For each stimulus frequency and at all times during the protracted stimuli, the destaining was 
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This approach provides a means to address the long-standing question of the fractional neurotransmitter released from terminals during stimulationdependent exocytosis. The data suggest that 0.03 to 0.21% of dopamine synaptic vesicles fused per stimulus, depending on the stimulation frequency (Fig. 3C) . The apparent low probability of release is consistent with cyclic voltammetry recordings that indicate that stimulation-dependent release of dopamine represents a very small fraction of that released with amphetamine (16) . There was a depression at more rapid stimulation, with twofold less destaining per pulse at 4 Hz and sixfold less destaining per pulse at 20 Hz than at 1 Hz (Fig. 3C) . If dopamine terminals are mostly releasing neurotransmitter by full fusion of the synaptic vesicle (17), these measurements indicate the fraction of transmitter accumulation-competent synaptic vesicles fused per stimulus and revealed a stimulationdependent form of presynaptic plasticity. The level of fractional destaining was enhanced with higher extracellular calcium (table S1), suggesting that frequency-dependent effects may be related to an activity-dependent decrease of calcium entry per stimulus, although other possibilities such as altered fusion mechanisms, depletion of a readily releasable pool, or decreased signal propagation through axons cannot be ruled out.
We next analyzed the heterogeneity within large ensembles of dopamine terminals in the striatum. The distribution of individual terminal activities showed a rightward skew at all stimulus frequencies when individual terminal half-times were displayed as histograms [P < 0.005, different from normal distribution by Kolmogorov-Smirnov (KS) test for all three frequencies] (Fig. 3D) . In normal probability plots, in which normally distributed data are linear, multimodal distributions can be seen that deviate further from normality with increased stimulus frequency (1 Hz, D = 0.0628; 4 Hz, D = 0.1160; 20 Hz, D = 0.1321; D statistics were obtained with the KS test and indicate the deviation from normality) (Fig. 3E) . All distributions were different from normal distribution and from each other (P < 0.005, KS test). The highly skewed distribution at 20 Hz indicates multiple populations of presynaptic terminals, including the most active population in which the probability of terminal content release per stimulus (P terminal ) is~0.2%, and the slowest population, with P terminal~0 .005%. The spatial distribution of presynaptic activity appeared to be complex, with very active and inactive terminals often nearby (Fig. 3F ). There was no relationship between initial fluorescent intensity and terminal destaining rates ( fig. S9) , suggesting that the heterogeneity in terminal activity was unrelated to the number of functional synaptic vesicles. To examine whether terminal heterogeneity may be due to variation in the depolarization of the terminals, we stimulated the same slice preparation at two frequencies and measured FFN511 destaining, first at 1 Hz and then at 20 Hz (Fig. 3, G and H) . The distribution of half-time values obtained from the same set of presynaptic terminals is well fit by a normal distribution at 1 Hz (D = 0.062, P > 0.1, KS test) (Fig. 3, G and H, blue) and is in an apparent multiple population distribution at 20 Hz that is not fit by a normal distribution (D = 0.194, P < 0.0001, KS test) (Fig. 3, G and H,  red) . This confirms that presynaptic terminal heterogeneity is stimulation frequency-dependent, although we cannot exclude the possibility that this is due to differences in axonal action potential propagation. Differential activity of individual glutamate presynaptic terminals has been observed by using either postsynaptic electrophysiological measurements (18, 19) or optical imaging, indicating membrane fusion (4); FFN511 reveals heterogeneity of dopamine release from individual terminals in the striatum and shows that this is a dynamic phenomenon dependent on stimulation frequency.
Cyclic voltammetry recordings in the striatum indicate that dopamine D2R activation inhibits the evoked release of dopamine in a frequencydependent manner (20) , and we thus examined how the frequency-dependent dopamine terminal heterogeneity was affected by the D2R antagonist sulpiride (10 mM for 20 min) (Fig. 4) . There was no significant change in the mean values of terminal kinetics at 1 and 4 Hz, although sulpiride accelerated release in the slow population of terminals more than one SD slower than the expected mean (Fig. 4, A and B) . At 20 Hz, however, sulpiride increased the mean t 1/2 by more than 50% (mean t 1/2 = 106.2 T 4.0 s for control versus 161.0 T 4.7 s for sulpiride), slowing the destaining kinetics of >65% of the terminals (Fig. 4C) (fig. S10B) . The phenomenon of frequency and pulse-dependent reversal of receptor inhibition of dopamine overflow has been identified using nicotinic antagonists (21, 22) . Thus the activity-dependent terminal heterogeneity is associated with receptor-mediated responses, and indicates the presence of frequency-dependent coding (23) that may determine how particular synapses are activated during decision-making, habit formation, and learning.
Spatial heterogeneity of dopamine release has been demonstrated by means of electrochemical recordings with a resolution of~100 mm (24) and has been suggested to play an important role in the modulation of synaptic circuitry involved in motivation, reward, and learning. Here we find that the activity of individual dopaminergic presynaptic terminals is modulated by neuronal activity and receptor activation. FFNs enable optical measurements of key presynaptic processes in the central nervous system, including accumulation of a vesicle transporter substrate and release by evoked activity or drugs such as amphetamine, at unprecedented spatial resolution. FFN511 is compatible with GFPbased tags, the FM1-43 endocytic marker, and other optical probes, which will allow the construction of fine-resolution maps of synaptic microcircuitry and presynaptic activity, particularly in regions such as the hippocampus and cortex where monoamine innervation can be too sparse for electrochemical recording. ) dissociates VP7 trimers into monomers, releasing VP7 from the virion, and initiates penetration-inducing conformational changes in the other outer-layer protein, VP4. We report the crystal structure at 3.4 angstrom resolution of VP7 bound with the Fab fragment of a neutralizing monoclonal antibody. The Fab binds across the outer surface of the intersubunit contact, which contains two Ca 2+ sites. Mutations that escape neutralization by other antibodies suggest that the same region bears the epitopes of most neutralizing antibodies. The monovalent Fab is sufficient to neutralize infectivity. We propose that neutralizing antibodies against VP7 act by stabilizing the trimer, thereby inhibiting the uncoating trigger for VP4 rearrangement. A disulfide-linked trimer is a potential subunit immunogen. R otaviruses are multilayered, non-enveloped particles with double-stranded RNA (dsRNA) genomes (1) . Four structural proteins form a complex, three-layered capsid, which packages two viral enzymes and 11 dsRNA genome segments. A double-layered particle (DLP) assembles in the cytoplasm, buds into the endoplasmic reticulum (ER), receives in this process a transient bilayer membrane, and ultimately acquires an outer layer of protein, viral protein 7 (VP7), in place of the transient envelope. VP7 must be present in sufficient quantity and must fold correctly in order to displace the intermediate membrane (2) (3) (4) . This unusual maturation pathway results in the coating of a cytoplasmically synthesized and assembled inner particle with an ER-synthesized glycoprotein, but with no intervening membrane in the mature virion.
The surface of the DLP is a T = 13 icosahedral lattice of the trimeric protein, VP6, anchored on a T = 1 inner layer of VP2 (Fig. 1A) . VP7 is likewise a trimer, stabilized by Ca 2+ ions (5) . It forms the outermost virion layer, also with T = 13 icosahedral packing, by capping the VP6 pillars (6) (7) (8) . Assembly of the VP7 shell locks into place a second outer-layer protein, VP4, which is anchored between VP6 pillars and protrudes above the VP7 layer (9, 10) . VP4 spikes mediate attachment to cells and undergo a sequence of conformational changes that lead to endosomal membrane penetration (11, 12) . Uncoating of VP7, probably by withdrawal of Ca
2+
, is necessary for these changes to occur (13) . Thus, VP7 participates both in a membrane-displacing assembly step and in a membrane-disrupting entry step.
Rotavirus infection is the principal cause of severe, dehydrating diarrhea in infants (14) . Live attenuated vaccines are now being introduced, but the efficacy and practicality of these vaccines in the impoverished settings in which most infant deaths from rotavirus occur have not yet been established (15) . VP7 and VP4 are the targets of neutralizing and protective antibodies, and the structures and immunogenicities of these proteins underlie ongoing efforts to produce next generation subunit vaccines. Viruses bearing VP7 of at least 15 different serotypes (designated G1 to G15) have been isolated, 11 from humans (16, 17) . Epitopes of a number of neutralizing monoclonal antibodies (mAbs) have been determined, but the lack of a three-dimensional structure has precluded systematic study of neutralization mechanisms.
We have determined the crystal structure of the rhesus rotavirus (RRV, serotype G3) VP7 trimer in complex with the Fab fragment of neutralizing mAb 4F8 (18) . The core of the subunit folds into two compact domains, with disordered N-and 
